FindTrial
Sign In

nonintervention

OTHER5 trials

Sponsors

Shanghai Pulmonary Hospital, Shanghai, China, Zhejiang Cancer Hospital, Henan Cancer Hospital, Shujun Yang

Conditions

Advanced NSCLCChineseCirculating Tumor CellsCirculating Tumor DNAHepatocellular CarcinomaMetastatic Colorectal CancerNon-Small Cell Lung CancerNon-small Cell Lung Cancer

Unknown Phase

Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation
NCT04137718
Shanghai Pulmonary Hospital, Shanghai, ChinaChinese, Non-Small Cell Lung Cancer
Start: 2019-10-25End: 2024-10-20Target: 50000Updated: 2019-12-27
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121
Shanghai Pulmonary Hospital, Shanghai, ChinaAdvanced NSCLC, Circulating Tumor Cells, Circulating Tumor DNA
Start: 2020-01-15End: 2020-12-15Target: 100Updated: 2020-01-18
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
CompletedNCT04266691
Zhejiang Cancer HospitalNon-small Cell Lung Cancer
Start: 2009-01-31End: 2019-06-30Updated: 2020-02-12
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
NCT05023720
Henan Cancer HospitalMetastatic Colorectal Cancer
Start: 2021-07-20End: 2022-12-21Target: 300Updated: 2022-04-01
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma
NCT05024539
Shujun YangHepatocellular Carcinoma
Start: 2021-06-20End: 2022-12-21Target: 300Updated: 2022-04-05

Related Papers

Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma
Cancers2022-02-063 citations